Categories: Coronavirus

Medicomp Systems Adds New Clinical Content to Address the Coronavirus Outbreak

WASHINGTON, Feb. 25, 2020 /PRNewswire/ —

WHAT:
With the recent outbreak of the coronavirus, Medicomp Systems has added new clinical content aimed at supporting the accurate diagnosis and documentation of suspected cases in the United States and globally.

BACKGROUND:
Medicomp’s clinical knowledge base team is constantly monitoring new and existing clinical diagnoses, guidelines and terminology to ensure systems and databases are up to date. Medicomp’s solutions have been updated to include additional terms and mappings to support the accurate documentation, reporting and treatment of the new COVID-19 coronavirus strain.

Medicomp has also updated its clinical AI engine to support full clinical workups for suspected cases and to help providers quickly find virus-related data within their EHRs, such as identifying patients who recently traveled to affected areas. All updates are available to MEDCIN and Quippe customers.

Given the potential pandemic conditions, Medicomp believes it’s imperative that providers have point-of-care access to information that supports the accurate diagnosis and treatment of the coronavirus. Medicomp will continue to update its content and knowledge base should standardized codes be modified to address the coronavirus or future health conditions that threaten the public’s well-being.

FOR MORE INFORMATION:
Medicomp is committed to providing its customers and partners with timely updates that help clinician end users quickly identify and treat affected patients. For more information on Medicomp’s new coronavirus content or for any questions about Medicomp’s clinical AI engine, please email info@medicomp.com.

Media Contact
Stacy State
Amendola Communications for Medicomp Systems
502.744.7409
sstate@acmarketingpr.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/medicomp-systems-adds-new-clinical-content-to-address-the-coronavirus-outbreak-301010210.html

SOURCE Medicomp Systems

Staff

Recent Posts

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

2 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

2 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

2 hours ago

Calm Nature CBD Gummies Ingredients: 2026 Consumer Analysis Examines Full Spectrum CBD Claims, Testing Standards, and Formulation Transparency

Independent report examines Calm Nature CBD Gummies full spectrum formulation, CO2 extraction claims, THC removal…

2 hours ago